Dynamic Capital Management’s AstraZeneca AZN Stock Holding History

Dynamic Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-148,651	Closed	-$10.1M	–	250
2017 Q2	$10.1M	Buy	+148,651	New	+$9.71M	2.29%	8
2017 Q1	–	Sell	-74,093	Closed	-$4.05M	–	278
2016 Q4	$4.05M	Buy	74,093 +3,686	+5%	+$209K	0.43%	62
2016 Q3	$4.63M	Buy	70,407 +50,371	+251%	+$3.29M	0.6%	34
2016 Q2	$1.21M	Sell	20,036 -29,224	-59%	-$1.7M	0.14%	238
2016 Q1	$2.77M	Buy	+49,260	New	+$2.96M	1.04%	14
2015 Q3	–	Sell	-6,100	Closed	-$389K	–	355
2015 Q2	$389K	Buy	+6,100	New	+$418K	0.1%	187
2015 Q1	–	Sell	-3,358	Closed	-$236K	–	255
2014 Q4	$236K	Buy	+3,358	New	+$240K	0.12%	227
2014 Q3	–	Sell	-7,398	Closed	-$550K	–	326
2014 Q2	$550K	Sell	7,398 -3,483	-32%	-$252K	0.15%	234
2014 Q1	$706K	Buy	+10,881	New	+$703K	0.23%	138
2013 Q3	–	Sell	-54,376	Closed	-$2.57M	–	417
2013 Q2	$2.57M	Buy	+54,376	New	+$2.77M	0.68%	32

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dynamic Capital Management's AZN Position: Q3 2017 in Review

Dynamic Capital Management sold out of AstraZeneca (AZN) in Q3 2017, closing a stake of 148,651 shares — an estimated $10.1M sold.

Dynamic Capital Management first reported a position in AZN in Q2 2013 and held it in 10 quarters. The position peaked at $10.1M in Q2 2017. 455 funds tracked by Wall St. Rank hold AZN as of Q3 2017.

Dynamic Capital Management reported no remaining AstraZeneca position as of Q3 2017 after selling out during the quarter.
Dynamic Capital Management sold 148,651 AstraZeneca shares in Q3 2017, an estimated $10.1M.
Dynamic Capital Management first reported a position in AstraZeneca in Q2 2013 and held it in 10 quarters.
Dynamic Capital Management's AstraZeneca position peaked at $10.1M in Q2 2017.
455 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2017.

Based on Dynamic Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.